Connor, Clark & Lunn Investment Management (CC&L)’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $9.23M | Sell |
|
|||||
|
2025
Q2 | $7.37M | Buy |
|
|||||
|
2025
Q1 | $8.18M | Buy |
|
|||||
|
2024
Q4 | $7.53M | Buy |
|
|||||
|
2024
Q3 | $3.15M | Buy |
|
|||||
|
2024
Q2 | $535K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $1.17M | Sell |
|
|||||
|
2023
Q3 | $2.19M | Buy |
|
|||||
|
2023
Q2 | $2.77M | Buy |
|
|||||
|
2023
Q1 | $1.4M | Buy |
|
|||||
|
2022
Q4 | $160K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $879K | Sell |
|
|||||
|
2020
Q3 | $1.1M | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $798K | Sell |
|
|||||
|
2018
Q3 | $2.93M | Buy |
|
|||||
|
2018
Q2 | $1.64M | Buy |
|
|||||
|
2018
Q1 | $454K | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $1.51M | Sell |
|
|||||
|
2013
Q4 | $2.37M | Buy |
|
|||||
|
2013
Q3 | $1.52M | Buy |
|
|||||
|
2013
Q2 | $805K | Buy |
|